Business Context and Reporting Period
This Form 6-K filing by NewGenIvf Group Limited covers the month of June 2026, specifically reporting on an announcement made on June 18, 2026. The Company, a foreign private issuer based in Bangkok, Thailand, entered into an Additional Share Purchase Agreement (Additional SPA) with PredicXion Group Limited (also known as K25.ai).
Key Financial Metrics and Transaction Details
The filing details a specific acquisition transaction rather than providing general financial statements for the period. Key metrics related to the transaction include:
- Acquisition Target: Additional 4% equity interest in PredicXion Group Limited.
- Total Consideration: US$4,000,000.
- Payment Structure:
- US$1,900,000 payable in cash or digital assets.
- 1,500,000 newly issued Class A ordinary shares of NewGenIvf Group Limited.
- Implied Valuation: US$100,000,000 for PredicXion Group Limited upon completion.
- Aggregate Ownership: NewGenIvf Group Limited's total ownership in PredicXion will increase to 10%.
The filing text does not provide clear values for the Company's overall revenue, profit, cash flow, margins, debt, or liquidity for the reporting period.
Material Changes and Payment Terms
The primary material change is the expansion of the Company's investment in PredicXion. Payment terms for the cash portion are as follows:
- Deposit: US$100,000 payable upon signing of the Additional SPA.
- Balance: US$1,900,000 payable on or before September 30, 2026.
The transaction is subject to the satisfaction of customary closing conditions.
Guidance, Risks, and Regulatory Matters
Regulatory Exemption: The 1,500,000 Class A ordinary shares issued as consideration will be issued in reliance on the exemption from registration requirements under Section 4(a)(2) of the Securities Act of 1933 and/or Regulation S. These shares will be classified as "restricted securities" under Rule 144.
Risks and Contingencies: The closing of the transaction is contingent upon the satisfaction of customary closing conditions. The filing does not provide specific management commentary on future guidance or other operational risks beyond the transaction specifics.
Key Facts for Investor Verification
- Verify the satisfaction of customary closing conditions required to finalize the acquisition.
- Confirm the method of payment for the US$1,900,000 balance (cash vs. digital assets) prior to the September 30, 2026 deadline.
- Review the full text of the Additional SPA (Exhibit 10.1) for specific representations, warranties, and covenants.
- Assess the impact of issuing 1,500,000 new Class A ordinary shares on existing shareholder dilution.
- Monitor the Company's liquidity to ensure the US$1,900,000 balance payment is met by the specified date.